These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18032423)

  • 1. Fluoroquinolone resistance in Neisseria meningitidis in Spain.
    Enríquez R; Abad R; Salcedo C; Pérez S; Vázquez JA
    J Antimicrob Chemother; 2008 Feb; 61(2):286-90. PubMed ID: 18032423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis.
    Shultz TR; White PA; Tapsall JW
    Antimicrob Agents Chemother; 2005 May; 49(5):1753-60. PubMed ID: 15855492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated.
    Vereshchagin VA; Ilina EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
    J Antimicrob Chemother; 2004 Apr; 53(4):653-6. PubMed ID: 14998987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C; de Jong A; Friederichs S; Cloeckaert A; Schwarz S
    J Antimicrob Chemother; 2007 May; 59(5):886-92. PubMed ID: 17369276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
    Beeton ML; Chalker VJ; Kotecha S; Spiller OB
    J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of quinolone resistance-determining region mutations and efflux pump expression in Neisseria meningitidis resistant to fluoroquinolones.
    Castanheira M; Deshpande LM; Jones RN; Farrell DJ
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):263-6. PubMed ID: 22321998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
    J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of quinolone resistance in Escherichia coli from wild birds.
    Jiménez Gómez PA; García de los Rios JE; Rojas Mendoza A; de Pedro Ramonet P; García Albiach R; Reche Sainz MP
    Can J Vet Res; 2004 Jul; 68(3):229-31. PubMed ID: 15352551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G).
    Preisler A; Mraheil MA; Heisig P
    J Antimicrob Chemother; 2006 Mar; 57(3):430-6. PubMed ID: 16431864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
    Preisler A; Heisig P
    J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN.
    Magallon A; Roussel M; Neuwirth C; Tetu J; Cheiakh AC; Boulet B; Varin V; Urbain V; Bador J; Amoureux L
    J Antimicrob Chemother; 2021 Jan; 76(2):297-304. PubMed ID: 33156919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of resistance to ciprofloxacin in Neisseria meningitidis in Brazil.
    Gorla MC; Cassiolato AP; Pinhata JMW; de Moraes C; Corso A; Gagetti P; Lemos AP
    J Med Microbiol; 2018 Mar; 67(3):286-288. PubMed ID: 29458676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance of Russian isolates of Neisseria gonorrhoeae to fluoroquinolones].
    Vereshchagin VA; Il'una EN; Malakhova MV; Zubkov MM; Sidorenko SV; Kubanova AA; Govorun VM
    Mol Gen Mikrobiol Virusol; 2005; (1):23-7. PubMed ID: 15790029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of plasmid-mediated quinolone resistance qnr genes in poultry and swine clinical isolates of Escherichia coli.
    Yue L; Jiang HX; Liao XP; Liu JH; Li SJ; Chen XY; Chen CX; Lü DH; Liu YH
    Vet Microbiol; 2008 Dec; 132(3-4):414-20. PubMed ID: 18573620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D.
    Rupp J; Solbach W; Gieffers J
    J Antimicrob Chemother; 2008 Jan; 61(1):91-4. PubMed ID: 18033786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.